|
|
|
||||||||||
Associate Professor, Department of Medicine, University of Western Ontario, London, Ontario, Canada
Professor, Department of Medicine, McMaster University, Hamilton, Ontario
Associate Professor, Department of Clinical Epidemiology and Biostatistics, McMaster University
Associate Professor, Department of Medicine, St. Joseph's Hospital, McMaster University
Clinical Professor, Department of Medicine, Laval University, Québec City, Québec, Canada
Chief, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario; Senior Scientist, Ottawa Health Research Institute, Ottawa
Professor, Department of Medicine, McMaster University
Associate Professor, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
Associate Professor, Department of Medicine, McGill University, Montreal
Associate Professor, Department of Medicine, University of Montreal, Montreal
Professor of Medicine, Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine of Northwestern University, Chicago, IL
Associate Professor, Department of Medicine, University of Montreal
Associate Professor of Medicine, University of Toronto, Toronto, Ontario
Research Co-ordinator, Henderson Research Centre, McMaster University
Professor, Department of Medicine, McMaster University
Reprints: Dr. Kovacs, London Health Sciences Centre, 800 Commissioners Rd. E., London N6A 4G5, ON, Canada, fax 519/685-8477, michael.kovacs{at}lhsc.on.ca
BACKGROUND: Some patients develop fatigue while taking warfarin, but causality is uncertain.
OBJECTIVE: To assess whether warfarin use is associated with fatigue.
METHODS: This investigation was a substudy of a randomized double-blind trial in 13 outpatient thromboembolism clinics. Subjects who had received one month of open-label warfarin therapy for venous thromboembolism due to a transient risk factor were randomly assigned to receive warfarin or placebo for 2 months and followed for another 9 months after stopping the study drug. Fatigue was measured using a Likert scale, and change of fatigue was measured by the patient's global rating.
RESULTS: In 87 subjects, the overall ratings of fatigue were 0.1 unit lower (95% CI 0.6 units lower to 0.4 units higher) while taking warfarin. Global rating for change in fatigue intensity showed no increase of fatigue with warfarin use.
CONCLUSIONS: The short-term use of warfarin was not associated with symptoms of fatigue.
Key Words: fatigue, warfarin
Published Online, March 15, 2005. www.theannals.com, DOI 10.1345/aph.1E531